Follow Us:
Emerging Strategies in the Personalized Treatment of Breast Cancer
This webcast is jointly provided by A. Webb Roberts Center for CME of Baylor Health Care System and CancerNet.
For more information visit: www.cancernetus.com
 |
 |
This activity is supported in part by an independent education grants from Eisai, Inc, Genentech, Novartis Pharmaceuticals Corporation, and Astrazeneca.
Release date: September 5, 2014
Valid through: September 5, 2015
Specialty: Cancer
Target Audience
This webcast is directed primarily to hematologists/oncologists, radiation oncologists, surgical oncologists, pathologists, researchers, pharmacists, registered nurses, physician assistants, nurse practitioners and fellows in training interested in new developments for treatment of breast cancer. No specific skill or knowledge other than a basic training in hematology/oncology is required for successful participation in this activity.
Statement of Need/Program Overview
This webcast is intended to improve care of patients with breast cancer by accelerating adoption of new guidelines and evidence-based practice change. In addition to chemotherapy and targeted therapy of breast cancer, this symposium will focus on individualized treatment options. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This enduring online activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.
This program consists of 5 continuing education activites.
Module 1 — Advances in Therapies for Breast Cancer 1 — 1.25 AMA PRA Category 1™ Credit Hours
Module 2 — Advances in Therapies for Breast Cancer 2 — 1.25 AMA PRA Category 1™ Credit Hours
Module 3 — Molecular Subtypes and Markers in Breast Cancer — 1.5 AMA PRA Category 1™ Credit Hours
Module 4 — Radiation Therapy Approaches in Breast Cancer — 1.25 AMA PRA Category 1™ Credit Hours